The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response

J Cell Biochem. 2013 May;114(5):1203-15. doi: 10.1002/jcb.24463.

Abstract

Polycomb-group proteins form multimeric protein complexes involved in transcriptional silencing. The Polycomb Repressive complex 2 (PRC2) contains the Suppressor of Zeste-12 protein (Suz12) and the histone methyltransferase Enhancer of Zeste protein-2 (Ezh2). This complex, catalyzing the di- and tri-methylation of histone H3 lysine 27, is essential for embryonic development and stem cell renewal. However, the role of Polycomb-group protein complexes in the control of the intestinal epithelial cell (IEC) phenotype is not known. We show that Suz12 and Ezh2 were differentially expressed along the intestinal crypt-villus axis. ShRNA-mediated Suz12 depletion in the IEC-6 rat crypt-derived cell line decreased Ezh2 expression and H3K27 di-trimethylation. Suz12-depleted cells achieved higher cell densities after confluence, with increased cyclin D2 and cyclin D3 protein levels, and increased STAT3 activation in post-confluent cells. Suz12 depletion specifically increased mostly developmental, cell adhesion and immune response gene expression, including neuronal and inflammatory genes. Suz12 depletion directly and indirectly de-regulated the IL-1β-dependent inflammatory response, as demonstrated by decreased MAPK p38 activation as opposed to JNK activation, and altered basal and stimulated expression of inflammatory genes, including transcription factors such as C/EBPβ. Of note, this positive effect on cell proliferation and inflammatory gene expression was revealed in the absence of the cyclin-dependent kinase inhibitor p16, a main target negatively regulated by PRC2. These results demonstrate that the PRC2 complex, in addition to keeping in check non-IEC differentiation pathways, insures the proper IEC response to cell density as well as to external growth and inflammatory signals, by controlling specific signaling pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Count
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Line
  • Cell Proliferation / drug effects
  • Enhancer of Zeste Homolog 2 Protein
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Epithelial Cells / pathology*
  • Gene Expression Regulation / drug effects
  • Histones / metabolism*
  • Inflammation / genetics
  • Inflammation / pathology*
  • Interleukin-1beta / pharmacology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Intestines / pathology*
  • Lysine / metabolism*
  • Methylation / drug effects
  • Mice
  • Microvilli / drug effects
  • Microvilli / metabolism
  • Microvilli / pathology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Polycomb Repressive Complex 2 / metabolism
  • Rats
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • beta Catenin / metabolism

Substances

  • Histones
  • Interleukin-1beta
  • STAT3 Transcription Factor
  • beta Catenin
  • EZH2 protein, rat
  • Enhancer of Zeste Homolog 2 Protein
  • Ezh2 protein, mouse
  • Polycomb Repressive Complex 2
  • Lysine